Comparison between Dev Accelerator IPO and Paramesu Biotech IPO.
Dev Accelerator IPO is a Mainboard Bookbuilding IPO proposed to list at BSE, NSE while Paramesu Biotech IPO is a Mainboard Bookbuilding proposed to list at BSE, NSE.
The total issue size of Dev Accelerator IPO is up to ₹143.35 Cr whereas the issue size of the Paramesu Biotech IPO is up to ₹600.00 Cr. The final issue price of Dev Accelerator IPO is ₹61.00 per share and of Paramesu Biotech IPO is .
| Dev Accelerator IPO | Paramesu Biotech IPO | |
|---|---|---|
| Face Value | ₹2 per share | ₹5 per share |
| Issue Price (Lower) | ₹56.00 per share | |
| Issue Price (Upper) | ₹61.00 per share | |
| Issue Price (Final) | ₹61.00 per share | |
| Discount (Retail) | ||
| Discount (Employee) | ||
| Market Lot Size | 235 shares | |
| Fresh Issue Size | 2,35,00,000 shares | 0 shares |
| Fresh Issue Size (Amount) | up to ₹143.35 Cr | up to ₹520.00 Cr |
| OFS Issue Size | 0 shares | 0 shares |
| OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹80.00 Cr |
| Issue Size Total | 2,35,00,000 shares | 0 shares |
| Issue Size Total (Amount) | up to ₹143.35 Cr | up to ₹600.00 Cr |
Dev Accelerator IPO opens on Sep 10, 2025, while Paramesu Biotech IPO opens on . The closing date of Dev Accelerator IPO and Paramesu Biotech IPO is Sep 12, 2025, and , respectively.
| Dev Accelerator IPO | Paramesu Biotech IPO | |
|---|---|---|
| Anchor Bid Date | Sep 09, 2025 | |
| Issue Open | Sep 10, 2025 | |
| Issue Close | Sep 12, 2025 | |
| Basis Of Allotment (Tentative) | Sep 15, 2025 | |
| Initiation of Refunds (Tentative) | Sep 16, 2025 | |
| Credit of Share (Tentative) | Sep 16, 2025 | |
| Listing date (Tentative) | Sep 17, 2025 | |
| Anchor Lockin End date 1 | Oct 15, 2025 | |
| Anchor Lockin End date 2 | Dec 13, 2025 |
Dev Accelerator IPO P/E ratio is 233.25, as compared to Paramesu Biotech IPO P/E ratio of .
| Dev Accelerator IPO | Paramesu Biotech IPO | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials | Company Financials (Restated Consolidated)Dev Accelerator Ltd.'s revenue increased by 62% and profit after tax (PAT) rose by 303% between the financial year ending with March 31, 2025 and March 31, 2024.
| Company Financials (Restated)
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 49.8 | 92.19 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | 36.8 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | 233.25 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | ₹550.14 Cr. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROE | 23.30% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | 25.95% | 18.13% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | 2.39 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | ₹0.26 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | 3.24% | 23.30% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
In the Dev Accelerator IPO Retail Individual Investors (RII) are offered 23,00,650 shares while in Paramesu Biotech IPO retail investors are offered 23,00,650 shares. Qualified Institutional Buyers (QIB) are offered 69,01,950 shares in Dev Accelerator IPO and 0 shares in Paramesu Biotech IPO.
| Dev Accelerator IPO | Paramesu Biotech IPO | |
|---|---|---|
| Anchor Investor Reservation | 1,03,52,925 shares | |
| Market Maker Reservation | 0 shares | 0 shares |
| QIB | 69,01,950 shares | 0 shares |
| NII | 34,50,975 shares | 0 shares |
| RII | 23,00,650 shares | 0 shares |
| Employee | 1,64,500 shares | 0 shares |
| Others | ||
| Total | 2,35,00,000 shares | 0 shares |
Dev Accelerator IPO subscribed 64.00x in total, whereas Paramesu Biotech IPO subscribed .
| Dev Accelerator IPO | Paramesu Biotech IPO | |
|---|---|---|
| QIB (times) | 20.30x | |
| NII (times) | 87.97x | |
| Big NII (times) | 78.94x | |
| Small NII (times) | 106.01x | |
| RII (times) | 164.89x | |
| Employee (times) | 17.60x | |
| Other (times) | ||
| Total (times) | 64.00x |
